Next, the positive correlation of PD1/PD-L1 inhibitors with hyperprogressive disease was found in advanced NSCLC and metastatic head and neck squamous cell carcinoma [56, 57]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.